From a GHK-Cu safety perspective, FDA drug approval requires comprehensive toxicological evaluations covering specific populations, long-term continuous exposure, and different administration routes
GLP-1 receptor activation enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects
Omar RF, Gelboin HV, Rahimtula AD (1996) Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A
Christopher Shade of Quicksilver Scientific
28 They found that GLP-1 RA use was associated with a lower risk of incident glaucoma (hazard ratio [HR] = .81), with the risk decreasing even further when GLP-1 RAs were used for longer than 3 years (HR = .71)
However, elevated levels may indicate underlying conditions such as liver disease, haematological disorders, or kidney impairment that require medical investigation and management